UCI – Das Tumorzentrum Bern - Navigation

Novak, Urban

{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Jutzi, J. T., Wampfler, J., Ionescu, C., Kronig, M., Jeker, B., Hoffmann, M., Reusser, I., Haslebacher, C., Sendi Stamm, S., Schletti, M., L\u00fcscher, B. P., Bacher, V., Wehrli, M., Daskalakis, M., Pabst, T., \u0026 Novak, U. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/217543\u0022\u003ECAR T-Cell Therapies for Patients With Relapsed and Refractory Aggressive Lymphomas: Real-World Experiences From a Single Center on the Use of Radiotherapy\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E43\u003C\/i\u003E(5), e70124.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Rioja-Blanco, E., Banz, Y., Schlapbach, C., Novak, U., Chiorazzo, T., Bertschi, N. L., Bernhardt, P., Grundler, P. V., van der Meulen, N. P., Grzmil, M., Schibli, R., \u0026 Behe, M. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/211588\u0022\u003E161Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas\u003C\/a\u003E. \u003Ci\u003EJournal of Nuclear Medicine\u003C\/i\u003E, \u003Ci\u003E66\u003C\/i\u003E(6), 909-915.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Kimby, E. K., Sch\u00e4r, S., Pirosa, M. C., Vanazzi, A., Mey, U. J. M., Rauch, D., Wahlin, B. E., Hitz, F., Hernberg, M., Johansson, A.-S., de Nully Brown, P., Hagberg, H., Ferreri, A. J. M. J., Krasniqi, F., Voegeli, M., Novak, U., Zander, T., Bersvendsen, H., Mamot, C., \u2026 Zucca, E. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/204539\u0022\u003ESix-month Rituximab-Lenalidomide regimen in advanced untreated Follicular Lymphoma: SAKK 35\/10 Trial 10-year Update\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(7), 1712-1719.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Angelillo, P., Alarcon Tomas, A., Campodonico, E., Novak, U., Gabellier, L., Blau, I. W., Kwon, M., Ram, R., Forcade, E., Besley, C., Vucinic, V., Kr\u00f6ger, N., Corral, L. L., Vydra, J., Ferrari, S., von Tresckow, B., Rubio, M. T., Hernani, R., Sica, S., \u2026 Ruggeri, A. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/189438\u0022\u003ESevere ICANS after CAR T-cell therapy and assessment of prevention with levetiracetam for seizure prophylaxis following CAR T-cell for DLBCL \u0026 PMBCL in Europe: a survey on behalf of the Cellular Therapy \u0026 Immunobiology Working Party (CTIWP) of the EBMT\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E60\u003C\/i\u003E(1), 100-102.","year":2025,"type":"Journal Article (Further Contribution)"},{"title":"Renders, S., Ngoya, M., Finel, H., Rubio, M.-T., Townsend, W. M., Schroers, R., Novak, U., Schaap, N., Aljurf, M., Helbig, G., Collin, M., Kobbe, G., Anne, H., P\u00e9rez-Sim\u00f3n, J. A. A., Bloor, A., Ghesquieres, H., Sureda, A., Schmitz, N., Glass, B., \u0026 Dreger, P. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44708\u0022\u003EAutologous stem cell transplantation in T-cell\/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(21).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Novak, U., Mooyaart, J. E., Daskalakis, M., Scheid, C., Gabellier, L., Yakoub-Agha, I., Ram, R., Forcade, E., L\u00f3pez-Corral, L., Nicholson, E., Galli, E., St\u00f6lzel, F., Bethge, W., Wagner-Drouet, E. M., Hoogenboom, J. D., Mielke, S., Arber, C., Simonetta, F., Chabannon, C., \u2026 Malard, F. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44764\u0022\u003EChoice of commercially available CAR-T cell products for r\/r DLBCL \u0026 PMBCL in Europe: a survey on behalf of the cellular therapy \u0026 immunobiology working party (CTIWP) of the EBMT\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E59\u003C\/i\u003E(11), 1631-1634.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Wiedemann, G., Bacher, U., Joncourt, R., Solly, F., Widmer, C. C., Zeerleder, S., Novak, U., Pabst, T., \u0026 Porret, N. A. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44732\u0022\u003EA Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E25\u003C\/i\u003E(16).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Borchmann, P., Ferdinandus, J., Schneider, G., Moccia, A., Greil, R., Hertzberg, M., Schaub, V., H\u00fcttmann, A., Keil, F., Dierlamm, J., H\u00e4nel, M., Novak, U., Meissner, J., Zimmermann, A., Mathas, S., Zijlstra, J. M., Foss\u00e5, A., Viardot, A., Hertenstein, B., \u2026 Diehl, V. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/195487\u0022\u003EAssessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial\u003C\/a\u003E. \u003Ci\u003EThe Lancet\u003C\/i\u003E, \u003Ci\u003E404\u003C\/i\u003E(10450), 341-352.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Dreyling, M., Doorduijn, J., Gin\u00e9, E., Jerkeman, M., Walewski, J., Hutchings, M., Mey, U., Riise, J., Trneny, M., Vergote, V., Shpilberg, O., Gomes da Silva, M., Lepp\u00e4, S., Jiang, L., Stilgenbauer, S., Kerkhoff, A., Jachimowicz, R. D., Celli, M., Hess, G., \u2026 Hoster, E. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177213\u0022\u003EIbrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network\u003C\/a\u003E. \u003Ci\u003EThe Lancet\u003C\/i\u003E, \u003Ci\u003E403\u003C\/i\u003E(10441), 2293-2306.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Berning, P., Shumilov, E., Maulhardt, M., Boyadzhiev, H., Kerkhoff, A., Call, S., Reicherts, C., Saidy, A. O., Aydilek, E., Hoffmann, M., Novak, U., Daskalakis, M., Schmitz, N., Stelljes, M., Wulf, G., Bacher, V. U., Lenz, G., \u0026 Pabst, T. N. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/175830\u0022\u003EChimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(3), 1-12.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Mandhair, H. K., Radpour, R., Westerhuis, M., Banz W\u00e4lti, Y. S., Humbert, M., Arambasic, M., Dengjel, J., Davies, A., Tschan, M. P., \u0026 Novak, U. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/173737\u0022\u003EAnalysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(2), 424-429.","year":2024,"type":"Journal Article (Original Article)"},{"title":"de Ramon Ortiz, C., Wang, S., Stathis, A., Bertoni, F., Zenz, T., Novak, U., \u0026 Simonetta, F. (2024). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171214\u0022\u003EHow to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E42\u003C\/i\u003E(1), e3237.","year":2024,"type":"Journal Article (Review)"},{"title":"Passweg, J. R., Baldomero, H., Ansari, M., Arber, C., Chalandon, Y., Daskalakis, M., Diepold, M., Diesch-Furlanetto, T., Duchosal, M. A., Gerull, S., G\u00fcng\u00f6r, T., Heim, D., Hitz, F., Holbro, A., Masouridi-Levrat, S., Nair, G., Novak, U., Pabst, T. N., Renner, C., \u2026 Halter, J. P. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172128\u0022\u003EHematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25\u00a0years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E42\u003C\/i\u003E(1), e3241.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Chamuleau, M. E. D., Stenner, F., Chitu, D. A., Novak, U., Minnema, M. C., Geerts, P., Stevens, W. B. C., Zenz, T., van Imhoff, G. W., Wu, K. L., Demandt, A. M. P., Kersten, M. J., Terpstra, W. E., Tick, L. W., Deeren, D., Van Den Neste, E., Gregor, M., Veelken, H., B\u00f6hmer, L. H., \u2026 Lugtenburg, P. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171151\u0022\u003ER-CODOX-M\/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON\/SAKK): final results of a multicentre, phase 3, open-label, randomised trial\u003C\/a\u003E. \u003Ci\u003EThe Lancet. Haematology\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(12), e966-e975.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Boyadzhiev, H., Mazzeo, P., Akhoundova Sanoyan, D., Daskalakis, M., Novak, U., Lenz, G., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172008\u0022\u003ECAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(12), e984.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Novak, U., Fehr, M., Sch\u00e4r, S., Dreyling, M., Schmidt, C., Derenzini, E., Zander, T., Hess, G., Mey, U., Ferrero, S., Mach, N., Boccomini, C., B\u00f6ttcher, S., Voegeli, M., Cairoli, A., Ivanova, V.-S., Menter, T., Dirnhofer, S., Scheibe, B., \u2026 Renner, C. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170406\u0022\u003ECombined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1\/2 trial of the European MCL network (SAKK 36\/13)\u003C\/a\u003E. \u003Ci\u003EEClinicalMedicine\u003C\/i\u003E, \u003Ci\u003E64\u003C\/i\u003E, 102221.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Messerli, C., Wiedemann, G., Porret, N., Nagler, M., Seipel, K., Jeker, B., Novak, U., Zeerleder, S. S., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169029\u0022\u003ECorrelation of peripheral chimeric antigen receptor T-cell (CAR-T cell) mRNA expression levels with toxicities and outcome in patients with diffuse large B-cell lymphoma (DLBCL)\u003C\/a\u003E. \u003Ci\u003ETurkish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E40\u003C\/i\u003E(3), 187-196.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Wahli, M. N., Hayoz, S., Hoch, D., Ryser, C. O., Hoffmann, M., Scherz, A., Schwacha-Eipper, B., H\u00e4fliger, S., Wampfler, J., Berger, M. D., Novak, U., \u0026 \u00d6zdemir, B. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86982\u0022\u003EThe role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex\u003C\/a\u003E. \u003Ci\u003EJournal of Cancer Research and Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E149\u003C\/i\u003E(7), 3847-3858.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Davies, A. J., Barrans, S., Stanton, L., Caddy, J., Wilding, S., Saunders, G., Mamot, C., Novak, U., McMillan, A., Fields, P., Collins, G. P., Stephens, R., Cucco, F., Sha, C., van Hoppe, M., Tooze, R., Davies, J. R., Griffiths, G., Schuh, A., \u2026 Johnson, P. W. M. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/165689\u0022\u003EDifferential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E41\u003C\/i\u003E(15), 2718-2723.","year":2023,"type":"Journal Article (Original Article)"},{"title":"von Matt, S., Bacher, V. U., Banz W\u00e4lti, Y. S., Mansouri Taleghani, B., Novak, U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/167114\u0022\u003EOutcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment\u003C\/a\u003E. \u003Ci\u003EMediterranean Journal of Hematology and Infectious Diseases\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(1), e2023025.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Penack, O., Peczynski, C., Koenecke, C., Polge, E., Kuhnl, A., Fegueux, N., Daskalakis, M., Kr\u00f6ger, N., Dreger, P., Besley, C., Schanz, U., Bloor, A., Ganser, A., Forcade, E., Corral, L. L., Passweg, J. R., Novak, U., Moiseev, I., Schoemans, H., \u2026 Peric, Z. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166564\u0022\u003ESevere cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party\u003C\/a\u003E. \u003Ci\u003EJournal for Immunotherapy of Cancer\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(4).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Huwyler, F. A. F., Kunz, R., Bacher, V. U., Hoffmann, M., Novak, U., Daskalakis, M., Banz W\u00e4lti, Y. S., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/166447\u0022\u003EEvaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(7).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Mamot, C., Wicki, A., Hasler-Strub, U., Riniker, S., Li, Q., Holer, L., B\u00e4rtschi, D., Zaman, K., von Moos, R., Dedes, K. J., Boos, L. A., Novak, U., Bodmer, A., Ritschard, R., Obermann, E. C., Tzankov, A., Ackermann, C., Membrez-Antonioli, V., Z\u00fcrrer-H\u00e4rdi, U., \u2026 Rochlitz, C. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/164774\u0022\u003EA multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer\u003C\/a\u003E. \u003Ci\u003EScientific Reports\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(1), 3705.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Novak, U., \u017derovnik, E., Taler-Ver\u010di\u010d, A., \u017dnidari\u010d, M., Zupan\u010di\u010d, B., \u0026 Grdadolnik, J. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172198\u0022\u003EAmyloid Formation of Stefin B Protein Studied by Infrared Spectroscopy\u003C\/a\u003E. \u003Ci\u003EFrontiers in Bioscience (Landmark Edition)\u003C\/i\u003E, \u003Ci\u003E28\u003C\/i\u003E(3), 46.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Zander, T., Pabst, T. N., Sch\u00e4r, S., Aebi, S., Mey, U., Novak, U., Lerch, E., Rhyner Agocs, G., Goede, J., Maniecka, Z., Hayoz, S., R\u00fcfer, A., Renner, C., \u0026 Driessen, C. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/120489\u0022\u003EAlternate-day dosing of pomalidomide in relapsed\/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E37\u003C\/i\u003E(3), 699-701.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Jeran, M., Romolo, A., Spasovski, V., Ho\u010devar, M., Novak, U., \u0160tukelj, R., \u0160u\u0161tar, V., Kisovec, M., Bedina Zavec, A., Kogej, K., Igli\u010d, A., Treb\u0161e, P., \u0026 Kralj-Igli\u010d, V. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172199\u0022\u003ESmall Cellular Particles from European Spruce Needle Homogenate\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E24\u003C\/i\u003E(5).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Lang, N., \u0026 Novak, U. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172696\u0022\u003ENumerous Hot Topics in Lymphoproliferative Disorders\u003C\/a\u003E. \u003Ci\u003ELeading Opinions - H\u00e4matologie Und Onkologie\u003C\/i\u003E.","year":2023,"type":"Journal Article (Further Contribution)"},{"title":"Lakomy, T., Akhoundova Sanoyan, D., Nilius, H. J. J., Kronig, M.-N., Novak, U., Daskalakis, M., Bacher, V. U., \u0026 Pabst, T. N. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/164510\u0022\u003EEarly Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome\u003C\/a\u003E. \u003Ci\u003EBiomolecules\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(2).","year":2023,"type":"Journal Article (Original Article)"},{"title":"Paoletti, F., Covaceuszach, S., Cassetta, A., Calabrese, A. N., Novak, U., Konarev, P., Grdadolnik, J., Lamba, D., \u0026 Goli\u010d Grdadolnik, S. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/165190\u0022\u003EDistinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg2\u003C\/a\u003E. \u003Ci\u003EProtein Science\u003C\/i\u003E, \u003Ci\u003E32\u003C\/i\u003E(2), e4563.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Hitz, F., Lang, N., Mey, U., Mingrone, W., Moccia, A., Taverna, C., Novak, U., Stenner, F., Schmidt, A., Mamot, C., Fischer, N., \u0026 Putora, P. M. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88999\u0022\u003EDecision-making among experts in advanced Hodgkin Lymphoma\u003C\/a\u003E. \u003Ci\u003EOncology\u003C\/i\u003E, \u003Ci\u003E101\u003C\/i\u003E(3), 159-165.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Penack, O., Peczynski, C., Koenecke, C., Polge, E., Sanderson, R., Yakoub-Agha, I., Fegueux, N., Daskalakis, M., Collin, M., Dreger, P., Kr\u00f6ger, N., Schanz, U., Bloor, A., Ganser, A., Besley, C., Wulf, G. G., Novak, U., Moiseev, I., Schoemans, H., \u2026 Peric, Z. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170645\u0022\u003EOrgan complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party\u003C\/a\u003E. \u003Ci\u003EFrontiers in Immunology\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E, 1252811.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Dislich, B., Hoch, D., Dirnhofer, S., Novak, U., \u0026 Banz W\u00e4lti, Y. S. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116828\u0022\u003EAn unusual pseudolymphoma in the context of necrotizing fasciitis: A case report\u003C\/a\u003E. \u003Ci\u003EMedicine\u003C\/i\u003E, \u003Ci\u003E101\u003C\/i\u003E(51), e32457.","year":2022,"type":"Journal Article (Further Contribution)"},{"title":"Heini, A., Bacher, V. U., Porret, N., Wiedemann, G., Legros, M., Stalder Zeerleder, D., Seipel, K., Novak, U., Daskalakis, M., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87350\u0022\u003EExperiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma\u003C\/a\u003E. \u003Ci\u003ECells\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(17).","year":2022,"type":"Journal Article (Original Article)"},{"title":"G\u00f6ssi, S., Bacher, V. U., Haslebacher, C., Nagler, M., Suter, F. M., Staehelin, C., Novak, U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86406\u0022\u003EHumoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(14).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Stathis, A., Mey, U. J. M., Sch\u00e4r, S., Hitz, F., Pott, C., Mach, N., Krasniqi, F., Novak, U., Schmidt, C., Hohloch, K., Kienle, D. L., Hess, D., Moccia, A. A., Unterhalt, M., Eckhardt, K., Hayoz, S., Forestieri, G., Rossi, D., Dirnhofer, S., \u2026 Hiddemann, W. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70690\u0022\u003ESAKK 35\/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E6\u003C\/i\u003E(13), 3911-3920.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Stoffel, T., Bacher, V. U., Banz W\u00e4lti, Y. S., Daskalakis, M., Novak, U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86080\u0022\u003EBeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Medicine\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(13).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Bertschinger, M., \u0026 Novak, U. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116969\u0022\u003ESpannende Daten zu aggressiven Lymphomen\u003C\/a\u003E. \u003Ci\u003ELeading Opinions. H\u00e4matologie \u0026 Onkologie\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E, 6-8.","year":2022,"type":"Conference Paper (Paper)"},{"title":"Heini, A., Bacher, V. U., Kronig, M.-N., Wiedemann, G., Novak, U., Zeerleder, S. S., Mansouri Taleghani, B., Daskalakis, M., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70016\u0022\u003EChimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E57\u003C\/i\u003E(6), 1010-1012.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Novak, U., Golobi\u010d, A., Klan\u010dnik, N., Moha\u010dek-Gro\u0161ev, V., Stare, J., \u0026 Grdadolnik, J. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87532\u0022\u003EStrong Hydrogen Bonds in Acetylenedicarboxylic Acid Dihydrate\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E23\u003C\/i\u003E(11).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Schmitt, A. M., Walter, M., Herbrand, A. K., J\u00f6rger, M., Moffa, G., Novak, U., Hemkens, L., \u0026 Kasenda, B. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/85276\u0022\u003ECharacteristics and survival of patients with cancer with intended off-label use-a cohort study\u003C\/a\u003E. \u003Ci\u003EBMJ Open\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(5), e060453.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Mathys, A., Bacher, V. U., Banz W\u00e4lti, Y. S., Legros, M., Mansouri Taleghani, B., Novak, U., \u0026 Pabst, T. N. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57810\u0022\u003EOutcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era Letter\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E40\u003C\/i\u003E(2), 292-296.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Novak, U. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116970\u0022\u003ECD19-gerichtete CAR-T-Zell-Therapie in der Schweiz: der klinische Alltag\u003C\/a\u003E. \u003Ci\u003ELeading Opinions. H\u00e4matologie \u0026 Onkologie\u003C\/i\u003E, 18-20.","year":2022,"type":"Conference Paper (Paper)"},{"title":"Bonfiglio, F., Bruscaggin, A., Guidetti, F., Terzi di Bergamo, L., Faderl, M. R., Spina, V., Condoluci, A., Bonomini, L., Forestieri, G., Koch, R., Piffaretti, D., Pini, K., Pirosa, M. C., Cittone, M. G., Arribas, A., Lucioni, M., Ghilardi, G., Wu, W., Arcaini, L., \u2026 Rossi, D. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/54249\u0022\u003EGenetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E139\u003C\/i\u003E(5), 732-747.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Mazzeo, P., Zinkernagel, M. S., Legros, M., Porret, N., Romagna, L., Haase, D., Lenz, G., Novak, U., Banz W\u00e4lti, Y. S., Pabst, T. N., \u0026 Bacher, V. U. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/67830\u0022\u003EComprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology\u003C\/a\u003E. \u003Ci\u003ECurrent Oncology\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(2), 766-776.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Pirosa, M. C., Zhang, L., Hitz, F., Novak, U., Hess, D., Terrot, T., Pascale, M., Mazzucchelli, L., Bertoni, F., Cavalli, F., Zucca, E., \u0026 Stathis, A. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43833\u0022\u003EA phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E63\u003C\/i\u003E(1), 117-123.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Messmer, A. S., Que, Y.-A., Schankin, C. J., Banz W\u00e4lti, Y. S., Bacher, V. U., Novak, U., \u0026 Pabst, T. N. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/53710\u0022\u003ECAR T-cell therapy and critical care : A\u00a0survival guide for medical emergency teams.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EWiener Klinische Wochenschrift\u003C\/i\u003E, \u003Ci\u003E133\u003C\/i\u003E(23-24), 1318-1325.","year":2021,"type":"Journal Article (Review)"},{"title":"Messmer, A. S., Que, Y.-A., Schankin, C. J., Banz W\u00e4lti, Y. S., Bacher, V. U., Novak, U., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/54247\u0022\u003ENovel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland\u003C\/a\u003E. \u003Ci\u003ECritical Care Explorations\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(10), e0552.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Berger, M. D., Trelle, S., B\u00fcchi, A. E., Jegerlehner, S., Ionescu, C., Lamy de la Chapelle, T., \u0026 Novak, U. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/54943\u0022\u003EImpact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E106\u003C\/i\u003E(7), 1923-1931.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Mandhair, H. K., Novak, U., \u0026 Radpour, R. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43857\u0022\u003EEpigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EWorld Journal of Stem Cells\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(6), 542-567.","year":2021,"type":"Journal Article (Review)"},{"title":"Novak, U., \u0026 Grdadolnik, J. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43629\u0022\u003EInfrared spectra of hydrogen bond network in lamellar perfluorocarboxylic acid monohydrates\u003C\/a\u003E. \u003Ci\u003ESpectrochimica Acta. Part A - Molecular and Biomolecular Spectroscopy\u003C\/i\u003E, \u003Ci\u003E253\u003C\/i\u003E, 119551.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Moccia, A. A., Aeppli, S., G\u00fcsewell, S., Bargetzi, M., Caspar, C., Br\u00fclisauer, D., Ebn\u00f6ther, M., Fehr, M., Fischer, N., Ghilardi, G., Krasniqi, F., Lang, N., Mey, U., Mingrone, W., Novak, U., Pfleger, C., Richter, P., R\u00fctti, M., Schmidt, A., \u2026 Hitz, F. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/39191\u0022\u003EClinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(2), 196-204.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Moccia, A. A., Sch\u00e4r, S., Hayoz, S., Pirosa, M. C., Taverna, C., Novak, U., Kimby, E., Ghielmini, M., \u0026 Zucca, E. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37180\u0022\u003EPrognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E192\u003C\/i\u003E(6), 1031-1034.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Herbrand, A. K., Schmitt, A. M., Briel, M., Ewald, H., Goldkuhle, M., Diem, S., Hoogkamer, A., Joerger, M., Moffa, G., Novak, U., Hemkens, L. G., \u0026 Kasenda, B. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43628\u0022\u003EAssociation of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs\u003C\/a\u003E. \u003Ci\u003EJAMA Network Open\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(3), e210380.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Pellegrini, L., Novak, U., Andres, M., Suter, T., \u0026 Nagler, M. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/40053\u0022\u003ERisk of bleeding complications and atrial fibrillation associated with ibrutinib treatment: A systematic review and meta-analysis\u003C\/a\u003E. \u003Ci\u003ECritical Reviews in Oncology Hematology\u003C\/i\u003E, \u003Ci\u003E159\u003C\/i\u003E, 103238.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Ferreri, A. J. M., Doorduijn, J. K., Re, A., Cabras, M. G., Smith, J., Ilariucci, F., Luppi, M., Calimeri, T., Cattaneo, C., Khwaja, J., Botto, B., Cellini, C., Nassi, L., Linton, K., McKay, P., Olivieri, J., Patti, C., Re, F., Fanni, A., \u2026 Cwynarski, K. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/43626\u0022\u003EMATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial\u003C\/a\u003E. \u003Ci\u003EThe Lancet. Haematology\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(2), e110-e121.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Nydegger, A., Novak, U., Kronig, M.-N., Legros, M., Zeerleder, S. S., Banz W\u00e4lti, Y. S., Bacher, V. U., \u0026 Pabst, T. N. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/58114\u0022\u003ETransformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(23).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Jeker, B., Daskalakis, M., Zeerleder, S. S., Pabst, T. N., \u0026 Novak, U. (2021, January). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/66610\u0022\u003ECAR T Cells: Immuntherapie mit grossem Potenzial\u003C\/a\u003E. \u003Ci\u003EOnkologie \u0026 H\u00e4matologie\u003C\/i\u003E, \u003Ci\u003E2021\u003C\/i\u003E, 16-19.","year":2021,"type":"Magazine Article"},{"title":"Zander, T., Pabst, T. N., Sch\u00e4r, S., Aebi, S., Pabst, T., Mey, U., Novak, U., Lerch, E., Rhyner, G., Goede, J., Maniecka, Z., Hayoz, S., Rufer, A., Renner, C., \u0026 Driessen, C. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116968\u0022\u003EP-227: Alternate day dosing of pomalidomide in patients with refractory\/relapsed multiple myeloma (RRMM): Results of a multicenter, single arm phase 2 trial (SAKK 39\/16 OptiPOM Study)\u003C\/a\u003E. \u003Ci\u003EClinical Lymphoma, Myeloma and Leukemia\u003C\/i\u003E, \u003Ci\u003E21\u003C\/i\u003E(Suppl. 2), S165.","year":2021,"type":"Journal Article (Further Contribution)"},{"title":"Siegenthaler, F. A., Imboden, S., L\u00f6ssl, K., Novak, U., Dingeldein, I., \u0026 Mueller, M. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/66455\u0022\u003EDie Vielfalt der malignen Tumore der Geb\u00e4rmutter\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Forum \u2012 Schweizerisches Medizin-Forum\u003C\/i\u003E, \u003Ci\u003E2021\u003C\/i\u003E(17\u201318), 290-296.","year":2021,"type":"Journal Article (Review)"},{"title":"Novak, U. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/39194\u0022\u003ECAR-T cell therapy of lymphoma: where do we stand? CAR-T will replace allo-SCT \u2013 PRO\u003C\/a\u003E. \u003Ci\u003ESchweizer Krebsbulletin Bulletin Suisse du Cancer\u003C\/i\u003E, \u003Ci\u003E40\u003C\/i\u003E(4), 295-299.","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Jeker, B., Farag, S. A. I., Mansouri Taleghani, B., Novak, U., Mueller, B. U., Li, Q., Betticher, D., Luethi, J.-M., Farese, S., Ruefer, A., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/54866\u0022\u003EA randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E55\u003C\/i\u003E(10), 2047-2051.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Benz, R., Arn, K., Andres, M., Pabst, T. N., Baumann, M., Novak, U., Hitz, F., Hess, U., Zenhaeusern, R., Chalandon, Y., Mey, U., Blum, S., Rauch, D., O\u2019Meara Stern, A., Cantoni, N., Bargetzi, M., Bianchi-Papina, E., Rossi, D., Passweg, J., \u2026 Stussi, G. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55354\u0022\u003EProspective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(15), 3699-3707.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Sula, M., Bacher, V. U., Oppliger Leibundgut, E., Mansouri Taleghani, B., Novak, U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/184146\u0022\u003EExcellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E55\u003C\/i\u003E(8), 1690-1693.","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Pabst, T. N., Joncourt, R., Shumilov, E., Heini, A., Wiedemann, G., Legros, M., Seipel, K., Schild, C., Jalowiec, K. A., Mansouri Taleghani, B., Fux, M., Novak, U., Porret, N., Zeerleder, S. S., \u0026 Bacher, V. U. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36540\u0022\u003EAnalysis of IL-6 serum levels and CAR-T cell specific digital PCR in the context of cytokine release syndrome (CRS)\u003C\/a\u003E. \u003Ci\u003EExperimental Hematology\u003C\/i\u003E, \u003Ci\u003E88\u003C\/i\u003E, 7-14e3.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Novak, U. (2020, June). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/39193\u0022\u003EUpdate zur CAR-T-Zell-Therapie\u003C\/a\u003E. \u003Ci\u003ELeading Opinions. H\u00e4matologie \u0026 Onkologie\u003C\/i\u003E, \u003Ci\u003E2020\u003C\/i\u003E(6), 6-9.","year":2020,"type":"Magazine Article"},{"title":"Mandhair, H. K., Arambasic, M., Novak, U., \u0026 Radpour, R. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36887\u0022\u003EMolecular modulation of autophagy: New venture to target resistant cancer stem cells.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EWorld Journal of Stem Cells\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(5), 303-322.","year":2020,"type":"Journal Article (Review)"},{"title":"Flach, J., Shumilov, E., Joncourt, R., Porret, N., Novak, U., Pabst, T. N., \u0026 Bacher, V. U. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/36139\u0022\u003ECurrent concepts and future directions for hemato-oncologic diagnostics.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECritical Reviews in Oncology, Hematology\u003C\/i\u003E, \u003Ci\u003E151\u003C\/i\u003E, 102977.","year":2020,"type":"Journal Article (Review)"},{"title":"Flach, J., Shumilov, E., Joncourt, R., Porret, N., Tchinda, J., Legros, M., Scarpelli, I., Hewer, E. W., Novak, U., Schoumans, J., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183632\u0022\u003EDetection of rare reciprocal RUNX1 rearrangements by next\u2010generation sequencing (NGS) in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EGenes, Chromosomes \u0026 Cancer\u003C\/i\u003E, \u003Ci\u003E59\u003C\/i\u003E(4), 268-274.","year":2020,"type":"Journal Article (Original Article)"},{"title":"B\u00fcrki, S., \u0026 Novak, U. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37213\u0022\u003EDual Mechanism of Severe Bleeding Diathesis in a Patient with CLL: Acquired Von Willebrand Syndrome and Ibrutinib - Mediated Platelets Dysfunction\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology \u0026 Oncology\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(3).","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Heini, A., Hugo, R., Berger, M. D., Novak, U., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183827\u0022\u003EA simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(1), 74-81.","year":2020,"type":"Journal Article (Original Article)"},{"title":"De Santiago de Benito, A., Jeker, B., Gfeller, E., Porret, N., Banz W\u00e4lti, Y. S., Novak, U., Bacher, V. U., \u0026 Pabst, T. N. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182223\u0022\u003EMolecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E105\u003C\/i\u003E(1), e9-e12.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Trachsel, M., Wertli, M. M., Novak, U., Berezowska, S. A., P\u00f6llinger, A., \u0026 Wenemoser, E. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55914\u0022\u003EEin protrahiertes \u00abfever of unknown origin\u00bb\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Forum\u003C\/i\u003E, \u003Ci\u003E20\u003C\/i\u003E(43-44), 616-619.","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Prediletto, I., Farag, S. A. I., Bacher, V. U., Jeker, B., Mansouri Taleghani, B., Bregy, R., Zander, T., Betticher, D., Egger, T., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182024\u0022\u003EHigh incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E54\u003C\/i\u003E(12), 1923-1925.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Moser, S., Bacher, V. U., Jeker, B., Mansouri Taleghani, B., Betticher, D., Ruefer, A., Egger, T., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182021\u0022\u003EAutologous stem cell transfusions on multiple days in patients with multiple myeloma \u2010 does it matter\u003C\/a\u003E? \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E37\u003C\/i\u003E(5), 649-651.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Shumilov, E., Flach, J., Joncourt, R., Porret, N., Wiedemann, G., Novak, U., Gfeller, E., Jeker, B., Amstutz, U., Pabst, T. N., \u0026 Bacher, V. U. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182789\u0022\u003EClinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E60\u003C\/i\u003E(10), 2588-2590.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Fassbind, P., Jeker, B., M\u00fcller, B. U., Bacher, V. U., Zimmerli, S., Endrich, O., Gahl, B., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/180299\u0022\u003EImproved survival rates of AML patients following admission to the intensive care unit\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E60\u003C\/i\u003E(10), 2423-2431.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Hitz, F., Kraus, M., Pabst, T. N., Hess, D., Besse, L., Silzle, T., Novak, U., Seipel, K., Rondeau, S., St\u00fcdeli, S., Vilei, S. B., Samaras, P., Mey, U., \u0026 Driessen, C. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182788\u0022\u003ENelfinavir and lenalidomide\/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I\/II Trial (SAKK 39\/10)\u003C\/a\u003E. \u003Ci\u003EBlood Cancer Journal\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(9), 70.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Herbrand, A., Schmitt, A., Briel, M., Diem, S., Ewald, H., Hoogkamer, A., Joerger, M., Mc Cord, K., Novak, U., Sricharoenchai, S., Hemkens, L., \u0026 Kasenda, B. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182808\u0022\u003EContrasting Evidence to Reimbursement Reality for Off-label use 1 (OLU) of Drug Treatments in Cancer Care \u2013 Rationale and Design of 2 the CEIT-OLU-project\u003C\/a\u003E. In \u003Ci\u003EESMO open\u003C\/i\u003E. Cold Spring Harbor Laboratory.","year":2019,"type":"Working Paper"},{"title":"Bachmann, K., Nebiker, M., Johner, C., Bregy, R., Schaller, A., Novak, U., \u0026 Jakob, S. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/164137\u0022\u003ERare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent Problem\u003C\/a\u003E. \u003Ci\u003EA\u0026A Practice\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(4), 96-98.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Amsler, I. G., Jeker, B., Mansouri Taleghani, B., Bacher, V. U., Betticher, D., Egger, T., Zander, T., Luethi, J.-M., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62633\u0022\u003EProlonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E60\u003C\/i\u003E(2), 511-514.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Herbrand, A. K., Schmitt, A. M., Briel, M., Diem, S., Ewald, H., Hoogkamer, A., Joerger, M., Mc Cord, K. A., Novak, U., Sricharoenchai, S., Hemkens, L. G., \u0026 Kasenda, B. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/184144\u0022\u003EContrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project\u003C\/a\u003E. \u003Ci\u003EESMO Open\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(6), e000596.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Novak, U. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/35481\u0022\u003EAggressive Lymphome \u0026 DLBCL \u2013 noch immer R-CHOP f\u00fcr alle\u003C\/a\u003E? \u003Ci\u003ELeading Opinions. H\u00e4matologie \u0026 Onkologie\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(4), 6-9.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Ferreri, A. J., Doorduijn, J. K., Cattaneo, C., Cabras, M. G., Smith, J., Ilariucci, F., Narni, F., Calimeri, T., Re, A., Khwaja, J., Botto, B., Cellini, C., Nassi, L., Linton, K., McKay, P., Olivieri, J., Patti, C., Re, F., Fanni, A., \u2026 Cwynarski, K. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/39190\u0022\u003ESequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E134\u003C\/i\u003E(Suppl. 1), 353.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Jeker, B., Pabst, T. N., \u0026 Novak, U. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62914\u0022\u003ECAR-T-Zelltherapie \u2013 eine neue Behandlungsoption\u003C\/a\u003E. \u003Ci\u003EInfo@Onkologie\u003C\/i\u003E, \u003Ci\u003E2019\u003C\/i\u003E(1), 18-20.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Davies, A., Cummin, T. E., Barrans, S., Maishman, T., Mamot, C., Novak, U., Caddy, J., Stanton, L., Kazmi-Stokes, S., McMillan, A., Fields, P., Pocock, C., Collins, G. P., Stephens, R., Cucco, F., Clipson, A., Sha, C., Tooze, R., Care, M. A., \u2026 Johnson, P. W. M. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/66289\u0022\u003EGene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial\u003C\/a\u003E. \u003Ci\u003EThe Lancet Oncology\u003C\/i\u003E, \u003Ci\u003E20\u003C\/i\u003E(5), 649-662.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Schnell, B. R., Seipel, K., Bacher, V. U., Jeker, B., Mueller, B. U., Banz W\u00e4lti, Y. S., Novak, U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182796\u0022\u003ERebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(2), e180.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Zucca, E., Rondeau, S., Vanazzi, A., \u00d8stenstad, B., Mey, U. J. M., Rauch, D., Wahlin, B. E., Hitz, F., Hernberg, M., Johansson, A.-S., de Nully Brown, P., Hagberg, H., Ferreri, A. J. M., Lohri, A., Novak, U., Zander, T., Bersvendsen, H., Bargetzi, M., Mingrone, W., \u2026 Kimby, E. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182805\u0022\u003EShort regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E134\u003C\/i\u003E(4), 353-362.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Burkhard, R., Keller, I., Arambasic, M., Juskevicius, D., Tzankov, A., Lundberg, P., Bruggmann, R., Dirnhofer, S., Radpour, R., \u0026 Novak, U. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/65363\u0022\u003ETIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-\u03baB mediated signaling in B-cells\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E104\u003C\/i\u003E(4), 766-777.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Shumilov, E., Novak, U., Jeker, B., Mansouri Taleghani, B., Bacher, V. U., \u0026 Pabst, T. N. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182795\u0022\u003EHematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients\u003C\/a\u003E. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(2), e176.","year":2019,"type":"Journal Article (Further Contribution)"},{"title":"Conconi, A., Zucca, E., Margiotta-Casaluci, G., Darling, K., Hasse, B., Battegay, M., Staehelin, C., Novak, U., Schmid, P., Scherrer, A., Dirnhofer, S., Kwee, I., Nassi, L., Cavalli, F., Gaidano, G., Bertoni, F., \u0026 Bernasconi, E. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/163962\u0022\u003EPopulation-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(5), 757-764.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Moor, I., Bacher, V. U., Jeker, B., Mansouri Taleghani, B., Mueller, B. U., Keller, H. P., Betticher, D., Egger, T., Novak, U., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59972\u0022\u003EPeripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E(12), 1599-1602.","year":2018,"type":"Journal Article (Further Contribution)"},{"title":"Bacher, V. U., Shumilov, E., Flach, J., Porret, N., Joncourt, R., Wiedemann, G., Fiedler, M., Novak, U., Amstutz, U., \u0026 Pabst, T. N. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62329\u0022\u003EChallenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EBlood Cancer Journal\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(11), 113.","year":2018,"type":"Journal Article (Review)"},{"title":"Driessen, C., M\u00fcller, R., Novak, U., Cantoni, N., Betticher, D., Mach, N., R\u00fcfer, A., Mey, U., Samaras, P., Ribi, K., Besse, L., Besse, A., Berset, C., Rondeau, S., Hawle, H., Hitz, F., Pabst, T. N., \u0026 Zander, T. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62561\u0022\u003EPromising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E132\u003C\/i\u003E(19), 2097-2100.","year":2018,"type":"Journal Article (Further Contribution)"},{"title":"Farag, S. A. I., Jeker, B., Bacher, V. U., Mansouri Taleghani, B., M\u00fcller, B. U., Novak, U., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59977\u0022\u003EDose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(4), 671-678.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Alva, L. C., Bacher, V. U., Seipel, K., Mansouri Taleghani, B., Mueller, B. U., Novak, U., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/59979\u0022\u003EIron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003ETransfusion\u003C\/i\u003E, \u003Ci\u003E58\u003C\/i\u003E(10), 2365-2373.","year":2018,"type":"Journal Article (Original Article)"},{"title":"G\u00f6ssi, U., Jeker, B., Mansouri Taleghani, B., Bacher, V. U., Novak, U., Betticher, D., Egger, T., Zander, T., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158491\u0022\u003EProlonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(2), 436-444.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Novak, U. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62913\u0022\u003EErstlinientherapie beim diffusen grosszelligen B-Zell-Lymphom: personalisierte Therapie oder alles R-CHOP\u003C\/a\u003E? \u003Ci\u003ESchweizer Zeitschrift F\u00fcr Onkologie\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E, 22-25.","year":2018,"type":"Journal Article (Further Contribution)"},{"title":"Jeker, B., Novak, U., Mansouri Taleghani, B., Baerlocher, G. M., Seipel, K., Mueller, B. U., Bigler, M., Betticher, D., Luethi, J.-M., Farese, S., Ruefer, A., \u0026 Pabst, T. N. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193109\u0022\u003ENSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E(2), 175-179.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Bargetzi, M., Baumann, R., Cogliatti, S., Dietrich, P.-Y., Duchosal, M., Goede, J., Hitz, F., Konermann, C., Lohri, A., Mey, U., Novak, U., Papachristofilou, A., Stenner, F., Taverna, C., Zander, T., \u0026 Renner, C. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/63256\u0022\u003EDiagnosis and treatment of follicular lymphoma: an update.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E148\u003C\/i\u003E, w14635.","year":2018,"type":"Journal Article (Review)"},{"title":"Scherz, A., Kroll, J., L\u00f6ssl, K., \u0026 Novak, U. (2018). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62911\u0022\u003E(De)Eskalierung bei der Behandlung des fr\u00fchen Mammakarzinoms\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Forum\u003C\/i\u003E, \u003Ci\u003E28\u003C\/i\u003E(25), 526-531.","year":2018,"type":"Journal Article (Review)"},{"title":"Cihoric, N., Tsikkinis, A., Vlaskou Badra, E., Glatzer, M., Novak, U., Scherz, A., Shelan, M., Soldatovic, I., Chittazhathu Kurian Kuruvilla, Y., Aebersold, D. M., \u0026 L\u00f6ssl, K. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/156731\u0022\u003EHighly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study\u003C\/a\u003E. \u003Ci\u003ERadiation Oncology\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(1), 202.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Jegerlehner, S., Rauch, A., \u0026 Novak, U. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/154984\u0022\u003ERecurrent Inflammatory Flares in HIV-Infected Patients: Consider Castleman Disease\u003C\/a\u003E! \u003Ci\u003EJournal of Investigative Medicine High Impact Case Reports\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(3), 2324709617725094.","year":2017,"type":"Journal Article (Further Contribution)"},{"title":"Lo Priore, E. F., Fliedner, M., Heverhagen, J., Novak, U., \u0026 Marschall, J. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/153465\u0022\u003EThe role of a surveillance programme for introducing peripherally inserted central catheters: a 2-year observational study in an academic hospital\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E147\u003C\/i\u003E(w14441), w14441.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Blum-Halter, V., Heini, A. D., Novak, U., Mansouri Taleghani, B., Baerlocher, G. M., Leibundgut, K., Seipel, K., Banz W\u00e4lti, Y. S., Bargetzi, M., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193001\u0022\u003EHematopoietic stem cell remobilization with vinorelbine and filgrastim in AML\u003C\/a\u003E. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E52\u003C\/i\u003E(5), 786-788.","year":2017,"type":"Journal Article (Further Contribution)"},{"title":"Oberson, J., Novak, U., Mansouri Taleghani, B., Baerlocher, G. M., Seipel, K., Mueller, B., Leibundgut, K., Zimmerli, S., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/193123\u0022\u003ERevisiting G-CSF Support for Hematologic Recovery after Autologous Transplantation in AML Patients\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology \u0026 Oncology\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(5), 1148.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Pestalozzi, B. C., Tausch, C., Dedes, K. J., Rochlitz, C., Zimmermann, S., von Moos, R., Winterhalder, R., Ruhstaller, T., Mueller, A., Buser, K., Borner, M., Novak, U., Nussbaum, C. U., Seifert, B., Bigler, M., Bize, V., Vilei, S. B., Rageth, C., \u0026 Aebi, S. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158392\u0022\u003EAdjuvant treatment recommendations for patients with ER-positive\/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26\/10)\u003C\/a\u003E. \u003Ci\u003EBMC Cancer\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(1), 265.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Stettler, J., Novak, U., Baerlocher, G. M., Seipel, K., Mansouri Taleghani, B., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192836\u0022\u003EAutologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy\u003C\/a\u003E. \u003Ci\u003ELeukemia \u0026 Lymphoma\u003C\/i\u003E, \u003Ci\u003E58\u003C\/i\u003E(5), 1076-1083.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Novak, U. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/162014\u0022\u003E\u0022Toys for boys?\u0022\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Forum\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(05), 122.","year":2017,"type":"Journal Article (Further Contribution)"},{"title":"Suter, T., \u0026 Novak, U. (2017). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/162013\u0022\u003EKardiologie: Der Preis f\u00fcrs \u00dcberleben \u2013 kardiovaskul\u00e4re Nebenwirkungen onkologischer Therapien\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Forum\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(03), 61-63.","year":2017,"type":"Journal Article (Review)"},{"title":"Gilli, S., Novak, U., Mansouri Taleghani, B., Baerlocher, G. M., Leibundgut, K., Banz W\u00e4lti, Y. S., Zander, T., Betticher, D., Egger, T., Rauch, D., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192871\u0022\u003EBeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E96\u003C\/i\u003E(3), 421-429.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Heini, A. D., Berger, M. D., Seipel, K., Mansouri Taleghani, B., Baerlocher, G. M., Leibundgut, K., Banz W\u00e4lti, Y. S., Novak, U., \u0026 Pabst, T. N. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192835\u0022\u003EConsolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E53\u003C\/i\u003E, 28-34.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Berger, M. D., Branger, G., Klaeser, B., Mansouri Taleghani, B., Novak, U., Banz W\u00e4lti, Y. S., M\u00fcller, B. U., \u0026 Pabst, T. N. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/131437\u0022\u003EZevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E34\u003C\/i\u003E(3), 133-139.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Rohner, E., Wyss, N. M., Heg-Bachar, Z., Faralli, Z., Mbulaiteye, S. M., Novak, U., Zwahlen, M., Egger, M., \u0026 Bohlius, J. F. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/134624\u0022\u003EHIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E138\u003C\/i\u003E(1), 45-54.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Juilland, M., Gonzalez, M., Erdmann, T., Banz W\u00e4lti, Y. S., Jevnikar, Z., Hailfinger, S., Tzankov, A., Grau, M., Lenz, G., Novak, U., \u0026 Thome, M. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147382\u0022\u003ECARMA1- and MyD88-dependent activation of Jun\/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E127\u003C\/i\u003E(14), 1780-1789.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Keller, S., Seipel, K., Novak, U., Mueller, B. U., Mansouri Taleghani, B., Leibundgut, K., \u0026 Pabst, T. N. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138996\u0022\u003ENeurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(7), 786-792.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Fricker, M., Dubach, P., Helbling, A., Diamantis, E., Villiger, P., \u0026 Novak, U. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138374\u0022\u003ENot all facial swellings are angioedemas\u003C\/a\u003E! \u003Ci\u003EJournal of Investigational Allergology \u0026 Clinical Immunology\u003C\/i\u003E, \u003Ci\u003E25\u003C\/i\u003E(2), 146-147.","year":2015,"type":"Journal Article (Further Contribution)"},{"title":"Castillo, J. J., Bower, M., Br\u00fchlmann, J., Novak, U., Furrer, H., Tanaka, P. Y., Besson, C., Montoto, S., Cwynarski, K., Abramson, J. S., Dalia, S., Bibas, M., Connors, J. M., Furman, M., Nguyen, M.-L., Cooley, T. P., Beltran, B. E., Collins, J. A., Vose, J. M., \u2026 Ribera, J.-M. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/126708\u0022\u003EPrognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study\u003C\/a\u003E. \u003Ci\u003ECancer Research\u003C\/i\u003E, \u003Ci\u003E121\u003C\/i\u003E(3), 423-431.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Klenke, F. M., Wirtz, C., Banz W\u00e4lti, Y. S., Keel, M., Klass, N. D., Novak, U., \u0026 Benneker, L. M. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/128269\u0022\u003EMultiple myeloma-associated amyloidoma of the sacrum: case report and review of the literature\u003C\/a\u003E. \u003Ci\u003EGlobal Spine Journal\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(2), 109-114.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Burkhard, R., Bhagat, G., Cogliatti, S. B., Rossi, D., Gaidano, G., Pasqualucci, L., \u0026 Novak, U. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129080\u0022\u003EBCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma\u003C\/a\u003E. \u003Ci\u003EHematological Oncology\u003C\/i\u003E, \u003Ci\u003E33\u003C\/i\u003E(1), 23-30.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Reber, R., Banz W\u00e4lti, Y. S., Garamv\u00f6lgyi, E., Perren, A., \u0026 Novak, U. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117036\u0022\u003EDetermination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry: a case series from the Inselspital, Bern, and a critical appraisal of this determination in Switzerland\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E143\u003C\/i\u003E, w13748.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Reber, R., Chan, W., \u0026 Novak, U. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/78534\u0022\u003EAssessing DLBCL subtypes by immunohistochemistry E-Letter in response to Gutierrez-Garcia et al\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E117: 4836-43\u003C\/i\u003E.","year":2011,"type":"Journal Article (Further Contribution)"},{"title":"Rinaldi, A., Mian, M., Chigrinova, E., Arcaini, L., Bhagat, G., Novak, U., Rancoita, P. M. V., De Campos, C. P., Forconi, F., Gascoyne, R. D., Facchetti, F., Ponzoni, M., Govi, S., Ferreri, A. J. M., Mollejo, M., Piris, M. A., Baldini, L., Soulier, J., Thieblemont, C., \u2026 Bertoni, F. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71819\u0022\u003EGenome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E117\u003C\/i\u003E(5), 1595-1604.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Novak, U., Pasqualucci, L., \u0026 Dalla-Favera, R. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/78543\u0022\u003EMolecular Biology of Lymphomas\u003C\/a\u003E. In V. D. DeVita, T. S. Lawrence, \u0026 S. A. Rosenberg (Eds.), \u003Ci\u003ECANCER: Principles \u0026 Practice of Oncology\u003C\/i\u003E. Lippincott Williams \u0026 Wilkins.","year":2011,"type":"Book Section"},{"title":"Novak, U., Basso, K., Pasqualucci, L., Dalla-Favera, R., \u0026 Bhagat, G. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76996\u0022\u003EGenomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E155\u003C\/i\u003E(3), 362-5.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Novak, U. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/78532\u0022\u003EMolekularbiologie maligner Lymphome f\u00fcr den Nichtspezialisten\u003C\/a\u003E. \u003Ci\u003ETherapeutische Umschau\u003C\/i\u003E, 501-4.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Novak, U. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71820\u0022\u003E[Molecular biology of malignant lymphomas for non-specialists]\u003C\/a\u003E. \u003Ci\u003ETherapeutische Umschau\u003C\/i\u003E, \u003Ci\u003E67\u003C\/i\u003E(10), 501-4.","year":2010,"type":"Journal Article (Further Contribution)"},{"title":"Novak, U., Rinaldi, A., Kwee, I., Nandula, S. V., Rancoita, P. M. V., Compagno, M., Cerri, M., Rossi, D., Murty, V. V., Zucca, E., Gaidano, G., Dalla-Favera, R., Pasqualucci, L., Bhagat, G., \u0026 Bertoni, F. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104836\u0022\u003EThe NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E113\u003C\/i\u003E(20), 4918-21.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Saito, M., Novak, U., Piovan, E., Basso, K., Sumazin, P., Schneider, C., Crespo, M., Shen, Q., Bhagat, G., Califano, A., Chadburn, A., Pasqualucci, L., \u0026 Dalla-Favera, R. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104835\u0022\u003EBCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma\u003C\/a\u003E. \u003Ci\u003EProceedings of the National Academy of Sciences of the United States of America - PNAS\u003C\/i\u003E, \u003Ci\u003E106\u003C\/i\u003E(27), 11294-9.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Novak, U., Grob, T. J., Baskaynak, G., Peters, U. R., Aebi, S., Zwahlen, D., Tschan, M., Kreuzer, K.-A., Oppliger Leibundgut, E., Cajot, J.-F., Tobler, A., \u0026 Fey, M. (2001). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/143789\u0022\u003EOverexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia\u003C\/a\u003E. \u003Ci\u003EAnnals of Oncology\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(7), 981-986.","year":2001,"type":"Journal Article (Original Article)"}]}